Drug Shortage Report for MAGNESIUM SULFATE INJECTION, USP
| Report ID | 136534 |
| Drug Identification Number | 02139499 |
| Brand name | MAGNESIUM SULFATE INJECTION |
| Common or Proper name | Magnesium Sulfate Injection 500 mg/mL PBP Vial 50 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MAGNESIUM SULFATE |
| Strength(s) | 500MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 50 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-04-01 |
| Estimated end date | Unknown |
| Actual end date | 2022-12-15 |
| Shortage status | Resolved |
| Updated date | 2022-12-15 |
| Company comments | On 100% allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v37 | 2022-12-15 | French | Compare |
| v36 | 2022-12-15 | English | Compare |
| v35 | 2022-12-06 | French | Compare |
| v34 | 2022-12-06 | English | Compare |
| v33 | 2022-10-07 | English | Compare |
| v32 | 2022-08-25 | English | Compare |
| v31 | 2022-04-22 | French | Compare |
| v30 | 2022-04-22 | French | Compare |
| v29 | 2022-04-22 | English | Compare |
| v28 | 2022-04-13 | French | Compare |
| v27 | 2022-04-13 | English | Compare |
| v26 | 2021-09-30 | French | Compare |
| v25 | 2021-09-30 | English | Compare |
| v24 | 2021-09-07 | French | Compare |
| v23 | 2021-09-07 | English | Compare |
| v22 | 2021-09-07 | English | Compare |
| v21 | 2021-07-29 | French | Compare |
| v20 | 2021-07-29 | English | Compare |
| v19 | 2021-07-29 | English | Compare |
| v18 | 2021-07-29 | English | Compare |